long intergenic non-protein coding RNA 2035Genealiases: []
Q-omics provides the consensus-scored LINC02035 profile across patient tissues and cancer cell-line models. LINC02035 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in UCS. Among the 18 cancer types available for tumor–normal comparison, LINC02035 is differentially expressed in 9, with the highest sampling consensus in HNSC. Additionally, LINC02035 RNA expression shows 20,149 significant gene co-expression associations, with the highest sampling consensus in KIRP. Together, these results highlight UCS, HNSC, and KIRP as cancer lineages where LINC02035 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02035 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02035 survival associations across molecular data types. LINC02035 RNA expression shows survival associations in the most cancer types (20), followed by mutation status (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02035 RNA expression–survival associations across cancer types. High LINC02035 expression shows unfavorable associations in OV and LIHC, but favorable associations in UCS, HNSC, ESCA and ACC. The UCS Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .001). Together, the overview and detailed table identify UCS as the clearest survival context for LINC02035 RNA expression.
This table summarizes LINC02035 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 9. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02035. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02035 shows lower tumor expression in LUAD, THCA and BRCA and higher tumor expression in HNSC, LIHC and CHOL. The HNSC box plot shows higher LINC02035 RNA expression in tumor versus normal tissue (log2 FC = +0.902, t-test p < 0.001).
This table shows molecular features associated with LINC02035 in patient tissues and cancer cell lines. In patient samples, LINC02035 shows the broadest associations at the RNA and protein expression levels, with KIRP recurring as the lineage with the largest associated feature set.
